Biotechnology & Pharmaceutical Services Outsourcing Market Worth $91.4 Billion By 2028

Published On: August 17, 2021

The global biotechnology & pharmaceutical services outsourcing market size is estimated to arrive at USD 91.4 billion by 2028. It is projected to develop by 5.2% CAGR during the forecast period.

The greater demand for biologics together with miniature molecules has initiated the growth of service range of Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), in favor of pharmaceutical as well as biotechnology manufacture.

Small sized biotech and Pharma companies are in front of the challenges like costly capability and short of important proficiency, whilst carrying out various functions like internal improvement, training & education, product design & development, regulatory affairs, product testing & validation and product maintenance.

Sequentially, this has produced profitable occasions for the enlargement of CROs and CMOs. Contract services are increasing and turning into planned, strategic, and targeted. These factors are likely to perform a crucial part in increasing the share of CROs and CMOs in the general market for biotechnology & pharmaceutical services outsourcing.

Ending of copyright, increasing pricing pressure and authoritarian challenges have caused reduction of margins in the pharmaceutical and biotech manufacturing. Contract services present savings in the prices to their customers in addition to, furthermore, assist in saving time consumed in the procedure and administration of a manufacture as well as research amenities.

Moreover, the outsourcing services help in conquer trade obstacles in doing business and make possible the entrance of the companies into overseas markets. Due to these compensations, a number of firms decide to contract out services instead of spending funds on manufacturing machineries and employing experienced manual labor.

 To request a sample copy or view summary of this report, "please" click the link below:

Further key findings from the report suggest:

• In terms of revenue share plus the CAGR, the Pharma end-use sector is likely to direct the biotechnology & pharmaceutical services outsourcing market, during the forecast period, because of the growing competition and pressure of pricing, the pharma companies contract out their in-house actions, on a bigger level

• In 2020, the consulting service sector dominated the market and is expected to maintain its leading place, during the forecast period

• Due to the existence of pharmaceutical and biotechnology companies, in addition to the high-pitched quality of the services presented by the CMOs and CROs within the region, North America was the leading local market for the biotechnology & pharmaceutical services outsourcing, in 2020

• On the other hand, Asia Pacific is expected to record the highest CAGR, during the forecast period, due to the enhanced authoritarian frameworks, the greater scope for savings of expenditure, accessibility of low-priced manual labor as well as skillful human resources, and speedy enlargement of the pharmaceutical and biotechnology business, within the region

• Pharmaceutical and biotechnology companies are, gradually more, choosing for the consulting services owing to the factors, like the rising figure of counterfeit cases and inconsistency in intellectual property rights

Million Insights segmented the global biotechnology & pharmaceutical services outsourcing market based on End Use, Service, and Region.

Biotech & Pharma Services Outsourcing Service Outlook (Revenue, USD Million, 2016 - 2028)
    • Consulting
        • Regulatory Compliance
        • Remediation
        • Quality Management Systems Consulting
        • Others
    • Auditing & Assessment
        • Regulatory Affairs
        • Clinical Trial Applications & Product Registration
        • Regulatory Writing & Publishing
        • Legal Representation
        • Others
    • Product Maintenance
    • Product Design & Development
    • Product Testing & Validation
    • Training & Education
    • Others

Biotech & Pharma Services Outsourcing End-use Outlook (Revenue, USD Million, 2016 - 2028)
    • Pharma Companies
    • Biotech Companies

Biotech & Pharma Services Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)
    • North America
        • U.S.
        • Canada
    • Europe
        • U.K.
        • Germany
        • France
        • Italy
        • Spain
    • Asia Pacific
        • Japan
        • China
        • India
        • Australia
        • South Korea
    • Latin America
        • Brazil
        • Mexico
        • Argentina
    • Middle East & Africa
        • South Africa
        • Saudi Arabia
        • UAE


Various companies for biotechnology & pharmaceutical services outsourcing market are:

    • ICON plc
    • Charles River Laboratories
    • Concept Heidelberg GmbH
    • Lachman Consultant Services, Inc.
    • IQVIA
    • PRA Health Sciences
    • Covance Inc.
    • GMP Pharmaceuticals Pty Ltd.
    • Parexel International Corporation
    • The Quantic Group